Fears and hopes of patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic across Europe. Results from the REUMAVID study (phase 1 and phase 2)

Musculoskeletal Care. 2023 Sep;21(3):932-935. doi: 10.1002/msc.1750. Epub 2023 Mar 8.

Marco Garrido-Cumbrera^{1

2

3}, Laura Christen⁴, Helena Marzo-Ortega^{5

6}, José Correa-Fernández¹, Sergio Sanz-Gomez¹, Victoria Navarro-Compán⁷

¹ Health & Territory Research (HTR), Universidad de Sevilla, Seville, Spain.
² Spanish Federation of Spondyloarthritis Associations (CEADE), Madrid, Spain.
³ Axial Spondyloarthritis International Federation (ASIF), London, UK.
⁴ Novartis Pharma AG, Basel, Switzerland.
⁵ NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust, Leeds, UK.
⁶ Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
⁷ IdiPaz, La Paz University Hospital, Madrid, Spain.

No abstract available

Keywords: COVID-19; Fears; Hopes; Patient Perspective; Patient-Reported Outcomes; Rheumatic Diseases.

Publication types